[1]
Utkin, Y. Brain and quantum dots: Benefits of nanotechnology for healthy and diseased brain. Cent. Nerv. Syst. Agents Med. Chem., 2018, 18(3), 193-205.
[2]
Shelukhina, I.V.; Zhmak, M.N.; Lobanov, A.V.; Ivanov, I.A.; Garifulina, A.I.; Kravchenko, I.N.; Rasskazova, E.A.; Salmova, M.A.; Tukhovskaya, E.A.; Rykov, V.A.; Slashcheva, G.A.; Egorova, N.S.; Muzyka, I.S.; Tsetlin, V.I.; Utkin, Y.N. Azemiopsin, a selective peptide antagonist of muscle nicotinic acetylcholine receptor: Preclinical evaluation as a local muscle relaxant. Toxins (Basel), 2018, 10(1) pii: E34
[3]
Tran, T.V.; Hoang, A.N.; Nguyen, T.T.T.; Phung, T.V.; Nguyen, K.C.; Osipov, A.V.; Ivanov, I.A.; Tsetlin, V.I.; Utkin, Y.N. Anticoagulant activity of low-molecular weight compounds from heterometrus laoticus scorpion venom. Toxins (Basel), 2017, 9(11)pii: E343
[4]
Vulfius, C.A.; Kasheverov, I.E.; Kryukova, E.V.; Spirova, E.N.; Shelukhina, I.V.; Starkov, V.G.; Andreeva, T.V.; Faure, G.; Zouridakis, M.; Tsetlin, V.I.; Utkin, Y.N. Pancreatic and snake venom presynaptically active phospholipases A2 inhibit nicotinic acetylcholine receptors. PLoS One,, 2017, 12(10) e0186206. 10.1371/journal.pone.0186206. eCollection 2017.
[5]
Dubovskii, P.V.; Dubinnyi, M.A.; Volynsky, P.E.; Pustovalova, Y.E.; Konshina, A.G.; Utkin, Y.N.; Arseniev, A.S.; Efremov, R.G. Impact of membrane partitioning on the spatial structure of an S-type cobra cytotoxin. J. Biomol. Struct. Dyn., 2018, 36(13), 3463-3478.
[6]
Osipov, A.V.; Terpinskaya, T.I.; Kuznetsova, T.E.; Ryzhkovskaya, E.L.; Lukashevich, V.S.; Rudnichenko, J.A.; Ulashchyk, V.S.; Starkov, V.G.; Utkin, Y.N. Cobra venom factor and ketoprofen abolish the antitumor effect of nerve growth factor from cobra venom. Toxins (Basel), 2017, 9(9)pii: E274
[7]
Alekseeva, A.S.; Tretiakova, D.S.; Chernikov, V.P.; Utkin, Y.N.; Molotkovsky, J.G.; Vodovozova, E.L.; Boldyrev, I.A. Heterodimeric V. nikolskii phospholipases A2 induce aggregation of the lipid bilayer. Toxicon, 2017, 133, 169-179.
[8]
Utkin, Y.N. Modern trends in animal venom research - omics and nanomaterials. World J. Biol. Chem., 2017, 8(1), 4-12.
[9]
Utkin, Y.N.; Cherepakhin, I.Y.; Kryukova, E.V.; Shelukhina, I.V.; Makarova, Y.V.; Kasheverov, I.E.; Mukherjee, A.K.; Gusev, A.A.; Kuznetsov, D.V. Conjugates of α-Cobratoxin with CdSe quantum dots: Preparation and biological activity. Nano Hybrid. Compos. 13, 3-8.
[10]
Vulfius, C.A.; Spirova, E.N.; Serebryakova, M.V.; Shelukhina, I.V.; Kudryavtsev, D.S.; Kryukova, E.; Starkov, V.G.; Kopylova, N.V.; Zhmak, M.N.; Ivanov, I.A.; Kudryashova, K.S.; Andreeva, T.V.; Tsetlin, V.I.; Utkin, Y.N. Peptides from puff adder Bitis arietans venom, novel inhibitors of nicotinic acetylcholine receptors. Toxicon, 2016, 121, 70-76.
[11]
Kudryavtsev, D.S.; Shelukhina, I.V.; Son, L.V.; Ojomoko, L.O.; Kryukova, E.V.; Lyukmanova, E.N.; Zhmak, M.N.; Dolgikh, D.A.; Ivanov, I.A.; Kasheverov, I.E.; Starkov, V.G.; Ramerstorfer, J.; Sieghart, W.; Tsetlin, V.I.; Utkin, Y.N. Neurotoxins from snake venoms and α-conotoxin imi inhibit functionally active ionotropic γ-aminobutyric acid (GABA) receptors. J. Biol. Chem., 2015, 290(37), 22747-22758.
[12]
Kudryavtsev, D.; Shelukhina, I.; Vulfius, C.; Makarievam, T.; Stonik, V.; Zhmak, M.; Ivanov, I.; Kasheverov, I.; Utkin, Y.; Tsetlin, V. Natural compounds interacting with nicotinic acetylcholine receptors: From low-molecular weight ones to peptides and proteins. Toxins (Basel), 2015, 7(5), 1683-1701.
[13]
Utkin, Y.N. Animal venom studies: Current benefits and future developments. World J. Biol. Chem., 2015, 6(2), 28-33.
[14]
Dubovskii, P.V.; Utkin, Y.N. Antiproliferative activity of cobra venom cytotoxins. Curr. Top. Med. Chem., 2015, 15(7), 638-648.
[15]
Vulfius, C.A.; Kasheverov, I.E.; Starkov, V.G.; Osipov, A.V.; Andreeva, T.V.; Filkin, S.Y.; Gorbacheva, E.V.; Astashev, M.E.; Tsetlin, V.I.; Utkin, Y.N. Inhibition of nicotinic acetylcholine receptors, a novel facet in the pleiotropic activities of snake venom phospholipases A2. PLoS One, 2014, 9(12)e115428
[16]
Osipov, A.V.; Terpinskaya, T.I.; Kryukova, E.V.; Ulaschik, V.S.; Paulovets, L.V.; Petrova, E.A.; Blagun, E.V.; Starkov, V.G.; Utkin, Y.N. Nerve growth factor from cobra venom inhibits the growth of ehrlich tumor in mice. Toxins (Basel), 2014, 6(3), 784-795.
[17]
Utkin, Y.N. Three-finger toxins, a deadly weapon of elapid venom--milestones of discovery. Toxicon, 2013, 62, 50-55.
[18]
Utkin, Y.N.; Weise, C.; Kasheverov, I.E.; Andreeva, T.V.; Kryukova, E.V.; Zhmak, M.N.; Starkov, V.G.; Hoang, N.A.; Bertrand, D.; Ramerstorfer, J.; Sieghart, W.; Thompson, A.J.; Lummis, S.C.; Tsetlin, V.I. Azemiopsin from Azemiops feae Viper Venom, a Novel Polypeptide Ligand of Nicotinic Acetylcholine Receptor. J. Biol. Chem., 2012, 287(32), 27079-27086.
[19]
Osipov, A.V.; Rucktooa, P.; Kasheverov, I.E.; Filkin, S.Y.; Starkov, V.G.; Andreeva, T.V.; Sixma, T.K.; Bertrand, D.; Utkin, Y.N.; Tsetlin, V.I. Dimeric alpha-Cobratoxin X-ray Structure: Localization of intermolecular disulfides and possible mode of binding to nicotinic acetylcholine receptors. J. Biol. Chem., 2012, 287(9), 6725-6734.
[20]
Alama, A.; Bruzzo, C.; Cavalieri, Z.; Forlani, A.; Utkin, Y.; Casciano, I.; Romani, M. Inhibition of the nicotinic acetylcholine receptors by cobra venom alpha-neurotoxins: is there a perspective in lung cancer treatment? PLoS One, 2011, 6(6)e20695
[21]
Konshina, A.G.; Boldyrev, I.A.; Utkin, Y.N.; Omel’kov, A.V.; Efremov, R.G. Snake cytotoxins bind to membranes via interactions with phosphatidylserine head groups of lipids. PLoS One, 2011, 6(4)e19064
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Computer-Aided Drug Design
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Current Drug Targets
Related Books
Drug Addiction Mechanisms in the Brain
Software and Programming Tools in Pharmaceutical Research
Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep
Frontiers in Clinical Drug Research - CNS and Neurological Disorders
Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems
Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19
Advanced Pharmacy
Plant-derived Hepatoprotective Drugs
The Role of Chromenes in Drug Discovery and Development
New Avenues in Drug Discovery and Bioactive Natural Products
Article Metrics
13